There's no question we've reached a turning point for Alzheimer's disease treatment.
Hope for Alzheimer's: Q&A with neurological disease expert retrieved 10 September 2024 from https://medicalxpress.com/news/2024-09-alzheimer-qa-neurological-disease-expert.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Lecanemab: Bittersweet moment for Alzheimer's patients - but hope of treatment is still possibleWhile the regulator of lecanemab has agreed that the drug can be prescribed in England, the NHS spending watchdog has ruled in draft guidance that it is too expensive to justify the benefits.
Read more »
Exploring early detection of Alzheimer's disease through non-cognitive symptomsThe article presents a thorough examination of Alzheimer's disease (AD), emphasizing early detection as critical due to the disease's progression through stages from normal cognition to mild cognitive impairment (MCI) and eventually dementia.
Read more »
FDA-approved Alzheimer's drug induces torpor-like state in tadpolesResearchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University report that they were able to successfully put tadpoles of Xenopus laevis frogs into a hibernation-like torpor state using donepezil (DNP), a drug approved by the FDA to treat Alzheimer’s.
Read more »
Dementia Australia welcomes UK approval of lecanemab to tackle Alzheimer’sDementia Australia welcomes the decision by the Medicines and Healthcare Products Regulatory Agency to approve Lecanemab for use in the UK.
Read more »
PET imaging and proteomics reveal distinct protein signatures in Alzheimer's disease progressionResearchers used PET imaging and proteomic analysis of cerebrospinal fluid to study amyloid β and tau tangle loads in Alzheimer's patients, identifying 127 proteins linked to disease progression. The findings highlight distinct molecular pathways and potential therapeutic targets.
Read more »
TV star Sian Reeves makes album in aid of Alzheimer'sLet me tell you about my lovely friend Sian Reeves, writes Alison Norton.
Read more »